Showing results (481-490 of 794) with videos related to
Sort By:
Pageof 80
Blood Cancer Journal|April 20, 2022
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, MinnesotaGeffen Kleinstern, Dirk R Larson, Cristine Allmer, et al.Mayo Clinic Proceedings|August 14, 2012
Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognitionTerry M Therneau, Robert A Kyle, L Joseph Melton, et al.Blood|February 5, 2011
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1S Vincent Rajkumar, Jean-Luc Harousseau, Brian Durie, et al.Blood Cancer Journal|May 27, 2021
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM)Sagar Lonial, Ajay K Nooka, Praneetha Thulasi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2021
Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTORHervé Avet-Loiseau, Jesus San-Miguel, Tineke Casneuf, et al.Blood|August 16, 2005
Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myelomaSagar Lonial, Edmund K Waller, Paul G Richardson, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 12, 2018
High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of ActionHomer C Adams, Frederik Stevenaert, Jakub Krejcik, et al.Biorxiv : the Preprint Server for Biology|April 3, 2026
Spatial multi-omics of multiple myeloma uncovers niche-dependent pro-myeloma and immunosuppressive signaling in the bone marrow and extramedullary lesionsDenis J Ohlstrom, Marina E Michaud, Mojtaba Bakhtiari, et al.Blood Cancer Discovery|November 15, 2021
Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom MacroglobulinemiaAkhilesh Kaushal, Ajay K Nooka, Allison R Carr, et al.Leukemia & Lymphoma|October 29, 2020
Retroperitoneal involvement with light chain amyloidosis- case series and literature reviewIuliana Vaxman, Alissa Visram, Oren Pasvolsky, et al.Pageof 80